Adalimumab and methotrextrate combination therapy in patient…
Adalimumab and methotrextrate combination therapy in patients with early RA sustains clinical remission and response through 5 years of adalimumab treatment.
Article, Chapter
Full text availability for this item
Journal:
RheumatologyOpens in new Window
Collection:
Oxford University Press Journals (UKB 2021-2023)
Coverage:
- 1996~present; volume:35~present;issue:1~present